Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes

NCT01011868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 10773 placebo
DRUG: BI 10773 low dose
DRUG: BI 10773 high dose
DRUG: BI 10773 placebo

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]